← Back to headlines
Eli Lilly's Experimental Drug Reduces Lung Cancer Recurrence Risk
Eli Lilly's experimental cancer drug has shown promise in reducing the risk of recurrence in patients with early-stage lung cancer.
19 Feb, 18:30 — 19 Feb, 18:30
Eli Lilly's experimental cancer drug has shown promise in reducing the risk of recurrence in patients with early-stage lung cancer.
19 Feb, 18:30 — 19 Feb, 18:30
